Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

DGX

Quest Diagnostics, Inc

Nov 03 • 04:00PM ET

178.84

+2.89 1.64 %

Healthcare • Diagnostics & Research • USA • NYSE

Peers: LH NEO EXAS OPK NTRA PMD

| Held by: VTI VOO VO IVV SPY VTV RSP XLV VOE VIG

Scroll to Statements

Index	S&P 500	P/E	20.99	EPS (ttm)	8.52	Insider Own	0.48%	Shs Outstand	111.00M	Perf Week	-0.79%
Market Cap	19.89B	Forward P/E	17.26	EPS next Y	10.36	Insider Trans	-9.56%	Shs Float	110.70M	Perf Month	-0.27%
Enterprise Value	25.96B	PEG	2.65	EPS next Q	2.36	Inst Own	98.29%	Short Float	3.57%	Perf Quarter	3.21%
Income	963.00M	P/S	1.83	EPS this Y	9.86%	Inst Trans	2.70%	Short Ratio	4.38	Perf Half Y	0.72%
Sales	10.85B	P/B	2.74	EPS next Y	5.62%	ROA	5.96%	Short Interest	3.95M	Perf YTD	18.55%
Book/sh	65.39	P/C	46.05	EPS next 5Y	7.91%	ROE	13.69%	52W High	197.55 -9.47%	Perf Year	14.69%
Cash/sh	3.88	P/FCF	14.28	EPS past 3/5Y	-20.98% 4.04%	ROIC	7.43%	52W Low	148.70 20.27%	Perf 3Y	25.37%
Dividend Est.	3.09 (1.73%)	EV/EBITDA	12.10	Sales past 3/5Y	-2.91% 5.02%	Gross Margin	32.05%	Volatility	2.14% 2.20%	Perf 5Y	40.65%
Dividend TTM	3.15 (1.76%)	EV/Sales	2.39	EPS Y/Y TTM	14.87%	Oper. Margin	14.62%	ATR (14)	3.93	Perf 10Y	177.49%
Dividend Ex-Date	Oct 03, 2025	Quick Ratio	1.04	Sales Y/Y TTM	13.74%	Profit Margin	8.88%	RSI (14)	44.99	Recom	2.23
Dividend Gr. 3/5Y	6.55% 7.19%	Current Ratio	1.13	EPS Q/Q	8.00%	SMA20	-1.89%	Beta	0.58	Target Price	198.38
Payout	39.15%	Debt/Eq	0.88	Sales Q/Q	13.18%	SMA50	-1.97%	Rel Volume	1.19	Prev Close	175.95
Employees	56000	LT Debt/Eq	0.79	Earnings	Oct 21 BMO	SMA200	2.71%	Avg Volume	902.76K	Price	178.84
IPO	Dec 17, 1996	Option/Short	Yes / Yes	EPS/Sales Surpr.	3.88% 2.94%	Trades		Volume	1,076,268	Change	1.64%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-25-25	Downgrade	Robert W. Baird	Outperform → Neutral	$194
Apr-02-25	Initiated	Redburn Atlantic	Buy	$195
Mar-04-25	Downgrade	Citigroup	Buy → Neutral	$185
Jan-06-25	Upgrade	Leerink Partners	Market Perform → Outperform	$169 → $174
Dec-17-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$145 → $172
Dec-10-24	Resumed	Jefferies	Buy	$175 → $185
Oct-23-24	Upgrade	Robert W. Baird	Neutral → Outperform	$157 → $182
Aug-28-24	Resumed	Evercore ISI	In-line	$165
Jul-10-24	Upgrade	Citigroup	Neutral → Buy	$145 → $165
Feb-26-24	Initiated	Leerink Partners	Market Perform	$135
Feb-07-24	Upgrade	Jefferies	Hold → Buy	$140 → $155
Jan-03-24	Initiated	Barclays	Equal Weight	$145
Dec-12-23	Upgrade	BofA Securities	Neutral → Buy	$140 → $160
Jun-29-23	Initiated	Piper Sandler	Neutral
May-02-23	Downgrade	BofA Securities	Buy → Neutral	$166 → $148
Apr-03-23	Upgrade	Citigroup	Sell → Neutral	$125 → $142
Jan-23-23	Initiated	Evercore ISI	In-line	$159
Nov-17-22	Downgrade	Citigroup	Neutral → Sell	$145 → $125
Aug-22-22	Resumed	Morgan Stanley	Equal-Weight	$142
Apr-04-22	Downgrade	Citigroup	Buy → Neutral	$175 → $140

Show Previous Ratings

Nov-03-25 04:09PM	Quest Diagnostics to Speak at Citi's 2025 Global Healthcare Conference (PR Newswire)
Oct-29-25 07:09PM	Analyst Report: Quest Diagnostics Incorporated (Morningstar Research)
Oct-27-25 09:40AM	Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term (Zacks)
07:45AM	New Study Demonstrates Accuracy of Two Quest AD-Detect Tests for Alzheimer's Disease Diagnosis (PR Newswire)
Oct-22-25 05:36PM	Quest Diagnostics Incorporated (DGX): A Bull Case Theory (Insider Monkey)
09:45AM	Loading…
09:45AM	Here's Why Quest Diagnostics (DGX) is a Strong Growth Stock (Zacks)
Oct-21-25 03:07PM	Analyst Report: Quest Diagnostics Incorporated (Morningstar Research)
03:02PM	Quest Diagnostics Inc (DGX) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
09:29AM	Quest Diagnostics Stock Up on Q3 Earnings & Revenue Beat, Margins Rise (Zacks)
07:55AM	Quest Diagnostics (DGX) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
06:59AM	Quest (NYSE:DGX) Posts Better-Than-Expected Sales In Q3 (StockStory)
06:52AM	Quest Diagnostics: Q3 Earnings Snapshot (Associated Press Finance)
06:45AM	Quest Diagnostics Reports Third Quarter 2025 Financial Results; Raises Guidance for Full Year 2025 (PR Newswire)
Oct-19-25 11:07PM	Quest (DGX) Reports Earnings Tomorrow: What To Expect (StockStory)
Oct-17-25 09:45AM	Tempus AI Fuels Growth Through Strategic Biotech Collaborations (Zacks)
02:53AM	Loading…
02:53AM	MVZ HPH Brings ctDNA Blood Test for Cancer Monitoring to Europe, Based on Haystack MRD Technology from Quest Diagnostics (PR Newswire)
Oct-14-25 12:10PM	Will Quest Diagnostics (DGX) Beat Estimates Again in Its Next Earnings Report? (Zacks)
10:00AM	Quest Diagnostics (DGX) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
08:38AM	Here's How Quest Diagnostics Is Placed Ahead of Q3 Earnings (Zacks)
Oct-13-25 07:58AM	Beat the Market the Zacks Way: MariMed, Xeris Biopharma, Lam Research in Focus (Zacks)
12:22AM	What to Expect From Quest Diagnostics Next Quarterly Earnings Report (Barchart)
Oct-09-25 09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Oct-03-25 09:45AM	Why Quest Diagnostics (DGX) is a Top Growth Stock for the Long-Term (Zacks)
Oct-01-25 10:17AM	Quest Diagnostics Joins Forces With Epic to Improve Laboratory Testing (Zacks)
08:00AM	Oura launches Ring 4 Ceramic collection, new charging case, and a health panel feature (TechCrunch)
Sep-30-25 09:05AM	DGX's Haystack Oncology Teams Up With Rutgers Cancer Institute (Zacks)
08:00AM	Whoop opens blood-testing service to what it says is a 350,000-person waitlist (TechCrunch)
Sep-26-25 06:53PM	Analyst Report: Quest Diagnostics Incorporated (Morningstar Research)
Sep-25-25 10:21AM	Zacks Industry Outlook Highlights Quest Diagnostics, DaVita, Addus HomeCare and The Pennant (Zacks)
10:00AM	Quest Diagnostics to Release Third Quarter 2025 Financial Results on October 21, 2025 (PR Newswire)
01:11PM	Loading…
Sep-24-25 01:11PM	4 Outpatient Home Health Stocks Worth Watching Amid Shifting Trends (Zacks)
08:05AM	Guardant Health and Quest Diagnostics Announce Strategic Collaboration to Broaden Access to Guardant's Shield Blood-based Screening Test in the United States (Business Wire)
05:26AM	Quest partners with Epic to boost laboratory testing services in US (Hospital Management)
Sep-23-25 09:40AM	Here's Why Quest Diagnostics (DGX) is a Strong Value Stock (Zacks)
07:07AM	Quest Diagnostics to Improve Laboratory Testing Experience with Industry-First Epic Collaboration (PR Newswire)
Sep-22-25 09:28AM	Is Quest Diagnostics Stock a Right Pick for Your Portfolio Now? (Zacks)
08:49AM	Is Quest Diagnostics Stock Underperforming the Dow? (Barchart)
08:07AM	Haystack Oncology and Rutgers Cancer Institute Collaborate in a Clinical Study to Examine Haystack MRD as a Guide for Post-Surgical Treatment for Lung Cancer (PR Newswire)
Sep-18-25 09:00AM	WHOOP to Bring Clinical Lab Testing from Quest Diagnostics to the WHOOP App (Business Wire)
Sep-17-25 01:17PM	Quest Diagnostics Incorporated (DGX): A Bull Case Theory (Insider Monkey)
09:45AM	Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Sep-15-25 06:21PM	Quest Diagnostics to Speak at the Jefferies Healthcare Services Conference (PR Newswire)
Sep-08-25 12:04AM	3 Reasons to Sell DGX and 1 Stock to Buy Instead (StockStory)
Sep-05-25 06:36AM	Quest Diagnostics introduces new pharmacogenomic testing service (Medical Device Network)
Sep-04-25 07:00PM	Quest Diagnostics: A Solid Investment or a Risky Bet? (Motley Fool)
09:32AM	Quest Diagnostics Launches Advanced Pharmacogenomics (PGx) Offering (PR Newswire)
Sep-03-25 11:35PM	Q2 Earnings Highs And Lows: Quest (NYSE:DGX) Vs The Rest Of The Testing & Diagnostics Services Stocks (StockStory)
11:30AM	Encompass Health (EHC) Up 8.6% Since Last Earnings Report: Can It Continue? (Zacks)
09:40AM	Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term (Zacks)
Sep-02-25 06:27AM	Fentanyl Positivity Is More Than Seven Times Higher in Random Tests vs. Pre-Employment Drug Screening, Finds 2025 Quest Diagnostics Drug Testing Index (PR Newswire)
05:00AM	More Fentanyl Shows Up in Random Workplace Tests (The Wall Street Journal)
Sep-01-25 09:45AM	Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio (Zacks)
Aug-28-25 11:30AM	Why Is Chemed (CHE) Up 9.3% Since Last Earnings Report? (Zacks)
10:05AM	HR professionals on the move in August (HR Dive)
09:50AM	Quest Diagnostics (DGX) is a Top-Ranked Momentum Stock: Should You Buy? (Zacks)
08:50AM	DGX Stock Gains Following a New Joint Venture With Corewell Health (Zacks)
Aug-26-25 11:40PM	Quest forms joint venture with Corewell Health (MedTech Dive)
09:00AM	Are Wall Street Analysts Predicting Quest Diagnostics Stock Will Climb or Sink? (Barchart)
09:00AM	Corewell Health and Quest Diagnostics to Enter into Joint Venture Providing Enhanced Laboratory Services in Michigan (PR Newswire)
06:38AM	FDA grants breakthrough device designation for Quest Diagnostics MRD test (Medical Device Network)
06:00AM	Tempus inks $81M Paige buyout to support AI model development (MedTech Dive)
Aug-25-25 09:36AM	Figma initiated, Okta upgraded: Wall Street's top analyst calls (The Fly)
08:52AM	FDA Grants Breakthrough Device Designation for Haystack MRD Circulating Tumor DNA Test from Quest Diagnostics (PR Newswire)
Aug-21-25 11:30AM	Why Is Quest Diagnostics (DGX) Up 8.2% Since Last Earnings Report? (Zacks)
10:14AM	Should Quest Diagnostics Stock Be in Your Portfolio Right Now? (Zacks)
Aug-20-25 09:00AM	What's Behind Hologic's Positive Long-Term Outlook for Cytology Unit? (Zacks)
Aug-18-25 09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Aug-15-25 06:14PM	Quest Diagnostics to Speak at the Baird 2025 Global Healthcare Conference (PR Newswire)
Aug-14-25 09:45AM	Here's Why Quest Diagnostics (DGX) is a Strong Growth Stock (Zacks)
Aug-13-25 06:35PM	Quest Diagnostics Declares Quarterly Cash Dividend (PR Newswire)
Aug-07-25 09:08AM	Mass General Brigham Launches Two Clinical Trials to Study Haystack MRD ctDNA as Guide for Post-surgical Treatment for Two Cancer Types (PR Newswire)
Aug-05-25 08:33AM	Quest Diagnostics Completes Acquisition of Clinical Testing Assets from Fresenius Medical Care (PR Newswire)
Jul-31-25 09:40AM	Why This 1 Value Stock Could Be a Great Addition to Your Portfolio (Zacks)
Jul-30-25 10:30AM	Exposure to PFAS in drinking water linked to higher blood levels of these "forever" chemicals (PR Newswire)
05:08AM	Drug Abuse Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad, Medtronic (GlobeNewswire)
Jul-29-25 08:52AM	Athena Diagnostics Improves Ataxia Movement Disorder Testing with Novel Long-Read Gene Sequencing (PR Newswire)
08:00AM	Quest, Labcorp downplay Big Beautiful Bill impact (MedTech Dive)
04:31AM	North America Autoimmune Disease Diagnostics Market Report 2025-2033 Featuring Bio-Rad, Abbott, Roche, Quest Diagnostics, Thermo Fisher Scientific, BioMerieux, Myriad Genetics, Siemens Healthineers (GlobeNewswire)
01:31AM	5 Must-Read Analyst Questions From Quest's Q2 Earnings Call (StockStory)
Jul-28-25 09:45AM	Why Quest Diagnostics (DGX) is a Top Growth Stock for the Long-Term (Zacks)
Jul-24-25 07:00AM	Labcorp raises annual profit forecast on strong diagnostic testing demand (Reuters)
05:00AM	Labcorp to buy some Community Health assets for $195M (MedTech Dive)
Jul-23-25 11:26AM	U.S. DTC Wellness Testing Market Forecast to 2030: A $1.91 Billion Opportunity Featuring Strategic Analysis of 23andMe, Everlywell, Quest Diagnostics and Other Industry Leaders (GlobeNewswire)
03:06AM	Quest Diagnostics Inc (DGX) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Raised ... (GuruFocus.com)
01:36AM	DGX Q2 Deep Dive: Acquisitions, Advanced Diagnostics, and Utilization Trends Drive Growth (StockStory)
Jul-22-25 01:10PM	Quest Diagnostics Raises Outlook, But Warns Of Tariff And Medicare Act Risks (Benzinga) +7.08%
01:10PM	Analyst Report: Quest Diagnostics Incorporated (Morningstar Research)
11:56AM	Why Quest (DGX) Stock Is Up Today (StockStory)
11:15AM	Danaher Q2 Earnings Beat Estimates, Life Sciences Sales Up Y/Y (Zacks)
08:39AM	Quest Diagnostics Beats Q2 Earnings & Revenue Estimates, Stock Rises (Zacks)
07:55AM	Quest Diagnostics (DGX) Beats Q2 Earnings and Revenue Estimates (Zacks)
07:05AM	Quest (NYSE:DGX) Surprises With Q2 Sales (StockStory)
06:58AM	Quest Diagnostics: Q2 Earnings Snapshot (Associated Press Finance)
06:47AM	Quest Diagnostics Reports Second Quarter 2025 Financial Results; Raises Guidance for Full Year 2025 (PR Newswire)
Jul-21-25 08:38AM	Should You Buy Quest Diagnostics Ahead of Earnings? (Zacks)
08:05AM	DGX Q2 Earnings Preview: Will Advanced Diagnostics Lead Performance? (Zacks)
Jul-20-25 11:04PM	Quest (DGX) Reports Q2: Everything You Need To Know Ahead Of Earnings (StockStory)
01:15PM	Donald Trump faces frosty reception on Aberdeen golf trip (Financial Times)
Jul-17-25 12:10PM	Will Quest Diagnostics (DGX) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Jul-15-25 09:40AM	Quest Diagnostics (DGX) is a Top-Ranked Value Stock: Should You Buy? (Zacks)

Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information, and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to physicians, hospitals, patients, and consumers. The All Other segment consists of risk assessment services and healthcare information technology. The company was founded in 1967 and is headquartered in Secaucus, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
PFEIFFER GARY M	Director	Oct 22 '25	Sale	182.40	1,482	270,317	29,431	Oct 24 06:10 PM
PFEIFFER GARY M	Director	Oct 22 '25	Proposed Sale	182.40	1,482	270,317		Oct 22 02:10 PM
PREVOZNIK MICHAEL E	SVP & General Counsel	Sep 26 '25	Option Exercise	103.57	227	23,510	38,344	Sep 30 04:36 PM
PREVOZNIK MICHAEL E	SVP & General Counsel	Sep 26 '25	Sale	188.13	227	42,706	38,117	Sep 30 04:36 PM
PREVOZNIK MICHAEL E	Officer	Sep 26 '25	Proposed Sale	188.13	227	42,706		Sep 26 04:12 PM
PREVOZNIK MICHAEL E	SVP & General Counsel	Sep 23 '25	Option Exercise	103.57	28,288	2,929,788	66,405	Sep 25 04:39 PM
PREVOZNIK MICHAEL E	SVP & General Counsel	Sep 24 '25	Option Exercise	103.57	175	18,125	38,292	Sep 25 04:39 PM
PREVOZNIK MICHAEL E	SVP & General Counsel	Sep 23 '25	Sale	187.12	28,288	5,293,313	38,117	Sep 25 04:39 PM
PREVOZNIK MICHAEL E	SVP & General Counsel	Sep 24 '25	Sale	187.02	175	32,729	38,117	Sep 25 04:39 PM
PREVOZNIK MICHAEL E	Officer	Sep 24 '25	Proposed Sale	187.02	175	32,729		Sep 24 04:10 PM
PREVOZNIK MICHAEL E	Officer	Sep 23 '25	Proposed Sale	187.12	28,288	5,293,313		Sep 23 04:14 PM
Plewman Patrick	SVP for Diagnostic Services	Aug 21 '25	Sale	185.00	1,975	365,375	15,269	Aug 25 04:27 PM
Plewman Patrick	SVP for Diagnostic Services	Aug 19 '25	Option Exercise	112.17	4,532	508,354	21,776	Aug 21 04:34 PM
Plewman Patrick	SVP for Diagnostic Services	Aug 19 '25	Sale	183.00	4,532	829,356	17,244	Aug 21 04:34 PM
Plewman Patrick	Officer	Aug 21 '25	Proposed Sale	185.00	1,975	365,375		Aug 21 12:10 PM
Plewman Patrick	SVP for Diagnostic Services	Aug 15 '25	Sale	180.00	1,975	355,500	17,244	Aug 19 04:47 PM
Plewman Patrick	Director	Aug 19 '25	Proposed Sale	183.00	4,532	829,356		Aug 19 04:09 PM
Plewman Patrick	Officer	Aug 15 '25	Proposed Sale	180.00	72	12,960		Aug 15 05:29 PM
Plewman Patrick	Officer	Aug 15 '25	Proposed Sale	180.00	1,903	342,540		Aug 15 05:22 PM
Plewman Patrick	SVP for Diagnostic Services	Aug 06 '25	Option Exercise	86.63	3,560	308,403	24,745	Aug 08 04:40 PM
Plewman Patrick	SVP for Diagnostic Services	Aug 06 '25	Sale	175.00	5,535	968,625	19,219	Aug 08 04:40 PM
Plewman Patrick	Officer	Aug 06 '25	Proposed Sale	175.00	5,535	968,625		Aug 06 01:54 PM
KUPPUSAMY KARTHIK	SVP, Clinical Solutions	Jul 30 '25	Option Exercise	102.77	8,269	849,764	15,884	Aug 01 04:37 PM
KUPPUSAMY KARTHIK	SVP, Clinical Solutions	Jul 30 '25	Sale	167.40	8,269	1,384,231	10,660	Aug 01 04:37 PM
KUPPUSAMY KARTHIK	SVP, Clinical Solutions	Jul 31 '25	Sale	170.00	2,210	375,700	8,450	Aug 01 04:37 PM
KUPPUSAMY KARTHIK	Officer	Jul 31 '25	Proposed Sale	170.00	2,210	375,700		Jul 31 02:27 PM
KUPPUSAMY KARTHIK	Officer	Jul 30 '25	Proposed Sale	167.40	8,269	1,384,231		Jul 30 03:59 PM
DELANEY MARK E	SVP & Chief Commercial Officer	May 12 '25	Sale	175.72	874	153,579	8,372	May 14 05:12 PM
DELANEY MARK E	SVP & Chief Commercial Officer	May 13 '25	Sale	175.31	874	153,221	7,498	May 14 05:12 PM
DELANEY MARK E	Officer	May 13 '25	Proposed Sale	175.31	874	153,221		May 13 09:59 AM
DELANEY MARK E	Officer	May 12 '25	Proposed Sale	175.72	874	153,579		May 12 10:01 AM
Davis J. E.	CEO and President	Apr 02 '25	Sale	168.46	39,191	6,602,074	127,623	Apr 04 08:29 PM
KUPPUSAMY KARTHIK	SVP, Clinical Solutions	Apr 02 '25	Sale	170.00	2,555	434,350	10,575	Apr 04 08:26 PM
Davis J. E.	Officer	Apr 02 '25	Proposed Sale	170.00	39,191	6,662,470		Apr 02 10:20 AM
KUPPUSAMY KARTHIK	Officer	Apr 02 '25	Proposed Sale	170.00	2,555	434,350		Apr 02 09:50 AM
PREVOZNIK MICHAEL E	SVP & General Counsel	Mar 17 '25	Sale	170.00	4,643	789,310	38,117	Mar 19 09:00 PM
PREVOZNIK MICHAEL E	Officer	Mar 17 '25	Proposed Sale	170.00	4,643	789,310		Mar 17 10:15 AM
Doherty Catherine T.	EVP, Regional Businesses	Mar 05 '25	Sale	174.13	5,370	935,078	68,068	Mar 07 07:23 PM
Doherty Catherine T.	EVP, Regional Businesses	Mar 04 '25	Sale	175.79	716	125,866	68,068	Mar 05 04:38 PM
PREVOZNIK MICHAEL E	SVP & General Counsel	Mar 04 '25	Sale	175.79	592	104,068	38,117	Mar 05 04:35 PM
Doherty Catherine T.	Officer	Mar 05 '25	Proposed Sale	174.13	5,370	935,078		Mar 05 09:59 AM
PREVOZNIK MICHAEL E	Officer	Mar 04 '25	Proposed Sale	175.79	592	104,068		Mar 04 10:20 AM
Doherty Catherine T.	Officer	Mar 04 '25	Proposed Sale	175.79	716	125,866		Mar 04 09:58 AM
PREVOZNIK MICHAEL E	SVP & General Counsel	Feb 27 '25	Sale	172.61	528	91,138	39,031	Feb 28 04:38 PM
Doherty Catherine T.	EVP, Regional Businesses	Feb 27 '25	Sale	172.61	824	142,231	69,178	Feb 28 04:35 PM
Doherty Catherine T.	Officer	Feb 27 '25	Proposed Sale	172.61	824	142,231		Feb 27 10:52 AM
PREVOZNIK MICHAEL E	Officer	Feb 27 '25	Proposed Sale	172.61	528	91,138		Feb 27 10:41 AM
PREVOZNIK MICHAEL E	SVP & General Counsel	Feb 20 '25	Sale	170.99	604	103,278	39,845	Feb 21 04:44 PM
Plewman Patrick	SVP for Diagnostic Services	Feb 19 '25	Sale	169.71	320	54,307	18,082	Feb 21 04:43 PM
Doherty Catherine T.	EVP, Regional Businesses	Feb 20 '25	Sale	170.99	899	153,720	70,457	Feb 21 04:41 PM
Doherty Catherine T.	EVP, Regional Businesses	Feb 19 '25	Sale	169.71	535	90,795	71,356	Feb 21 04:41 PM
PREVOZNIK MICHAEL E	Officer	Feb 20 '25	Proposed Sale	170.99	604	103,278		Feb 20 10:01 AM
Doherty Catherine T.	Officer	Feb 20 '25	Proposed Sale	170.99	899	153,720		Feb 20 09:56 AM
Gregg Vicky B	Director	Feb 05 '25	Sale	164.57	1,250	205,710	16,867	Feb 07 04:37 PM
DELANEY MARK E	SVP & Chief Commercial Officer	Feb 05 '25	Sale	164.30	403	66,214	4,624	Feb 07 04:36 PM
DELANEY MARK E	Officer	Feb 05 '25	Proposed Sale	164.30	403	66,214		Feb 05 05:06 PM
Gregg Vicky B	Director	Feb 05 '25	Proposed Sale	164.57	1,250	205,710		Feb 05 04:00 PM
DELANEY MARK E	Officer	Jan 31 '25	Proposed Sale	164.85	2,615	431,094		Jan 31 01:12 PM
PREVOZNIK MICHAEL E	SVP & General Counsel	Nov 29 '24	Option Exercise	86.63	35,146	3,044,698	73,624	Dec 02 04:43 PM
PREVOZNIK MICHAEL E	SVP & General Counsel	Nov 29 '24	Sale	163.07	35,146	5,731,302	38,478	Dec 02 04:43 PM
Doherty Catherine T.	EVP, Regional Businesses	Nov 27 '24	Option Exercise	103.57	33,103	3,428,478	101,515	Dec 02 04:41 PM
Doherty Catherine T.	EVP, Regional Businesses	Nov 27 '24	Sale	162.99	33,103	5,395,484	68,412	Dec 02 04:41 PM
PREVOZNIK MICHAEL E	Officer	Nov 29 '24	Proposed Sale	163.07	35,146	5,731,302		Nov 29 02:42 PM
Doherty Catherine T.	Officer	Nov 27 '24	Proposed Sale	162.99	33,103	5,395,484		Nov 27 04:12 PM
DEPPE MICHAEL J	SVP, Corp. Controller & CAO	Nov 06 '24	Option Exercise	68.66	18,755	1,287,634	53,696	Nov 07 05:21 PM
DEPPE MICHAEL J	SVP, Corp. Controller & CAO	Nov 06 '24	Sale	154.05	18,755	2,889,123	34,941	Nov 07 05:21 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

DGX

Quest Diagnostics, Inc

Upgrade your FINVIZ experience